2022
DOI: 10.1016/j.oraloncology.2022.106115
|View full text |Cite
|
Sign up to set email alerts
|

Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 29 publications
1
4
0
Order By: Relevance
“…Similar to a recent study by Beom Heo et al, other adverse features found in our cohort do not seem to have a great impact on the clinical outcomes of the patients. Gross ETE was present in 1 patient and microscopic ETE occurred in 122 of 74 patients (30%).…”
Section: Discussionsupporting
confidence: 91%
“…Similar to a recent study by Beom Heo et al, other adverse features found in our cohort do not seem to have a great impact on the clinical outcomes of the patients. Gross ETE was present in 1 patient and microscopic ETE occurred in 122 of 74 patients (30%).…”
Section: Discussionsupporting
confidence: 91%
“…In current clinical management guidelines, multifocality is not considered a stand-alone prognostic factor [4,9]. It has been reported in several large case series that multifocality is not related to recurrence or clinical outcomes in PTCs [10,[52][53][54]. On the other hand, some studies found a significant relationship between multifocality and adverse prognostic features, including higher tumor stage [25,28,42,44,55], higher risk for LNM [18,19,25,26,28,43,49,[55][56][57][58][59][60][61][62], and higher rate of recurrence [10,27,28,30,44,56,63].…”
Section: Discussionmentioning
confidence: 99%
“…In various studies, multifocality [14,15] lymph node involvement [16], extrathyroidal extension [17], and papillary thyroid carcinoma (PTC) [18] in initial surgical pathology, high serum thyroglobulin level [17] and middle age (30-49 years) [18] have been reported as factors that can predict malignancy in the contralateral lobe. However, a recent comprehensive retrospective study found that multifocality, lymphovascular invasion, extrathyroidal spread to the strap muscles, or 5 or more central lymph node micro-metastases may not require immediate CTx in patients whose thyroid lobectomy specimen was papillary thyroid carcinoma [19]. It is important to understand that current guidelines appear to recommend CTx in the presence of various factors that we and many other researchers have not identified to be risk factors for malignancy.…”
Section: Clinical Researchmentioning
confidence: 91%
“…There is no consensus on which patients should be administered CTx after HTx [14,15]. Studies on the subject offer contradictory results [14,[16][17][18][19] and the current guidelines [6,20,21] do not seem to meet the needs of clinical practice.…”
Section: Introductionmentioning
confidence: 99%